CiNTL Launches a Contract Research Organization 

January 2, 2024 

 

In a momentous stride towards redefining the landscape of clinical research, C. International (CiNTL) proudly announces the launch of CiNTL Pharma B.V., A Contract Research Organization. 

 

Leiden, The Netherlands, January 2, 2024 -- In a momentous stride towards redefining the landscape of clinical research, C. International (CiNTL) proudly announces the launch of CiNTL Pharma B.V., an avant-garde Contract Research Organization (CRO) poised to set new standards of excellence in the pharmaceutical domain. Driven by a relentless pursuit of innovation and fueled by unparalleled expertise, CiNTL Pharma emerges as the beacon of excellence in clinical research. Spearheaded by the visionary leadership of CEO Yolanda Cabrera-Sybesma, CiNTL Pharma stands at the forefront of technology advancements, poised to expedite the drug development process through the seamless integration of artificial intelligence (AI), machine learning and global project management expertise.

​

At the core of CiNTL Pharma's ethos lies a steadfast commitment to excellence and impact. With a vision to ascend as the preeminent CRO, CiNTL Pharma is dedicated to delivering exceptional services empowered by advanced AI technologies. Our mission is clear: to optimize clinical research processes, drive efficiency, and ensure the delivery of unparalleled results for pharmaceutical and biotechnology companies worldwide.

​

With a strategic focus on managing global programs/projects and leveraging data-driven strategies, CiNTL Pharma endeavors to enhance the drug development lifecycle, catalyzing transformative breakthroughs for our esteemed partners. Through organic growth, strategic acquisitions, and impactful partnerships with leading pharmaceutical companies, CiNTL Pharma is poised to chart new pathways to success, shaping the future of clinical research.

​

"CiNTL Pharma was founded with a singular vision: to redefine the contours of clinical research and empower our clients to achieve unprecedented success," remarks Drs. Cabrera-Sybesma. "Backed by a team of seasoned pmp/agile experts and driven by a passion for innovation and led by compassion, we are committed to delivering results that surpass expectations, making us the trusted partner of choice for pharmaceutical and biotechnology companies worldwide."

​

As we embark on this transformative journey, we invite pharmaceutical companies to join us in shaping the future of clinical research. Explore our visionary initiatives, witness the power of innovation, and experience excellence like never before.

​

Mark your calendars: www.CiNTLPharma.com will go live on March 15, 2024, ushering in a new era of possibilities in clinical research.

​

For media inquiries, partnerships, or collaborations, please contact CiNTL Pharma Business Developement at BD@cintlpharma.com

​

Witness the future of data driven clinical research, led by compassion - Experience CiNTL Pharma today.

​

CiNTL Pharma B.V. is a leading Contract Research Organization (CRO) committed to delivering exceptional clinical research development services to the pharmaceutical and biotechnology industry. Backed by advanced AI technologies and a team of seasoned professionals, CiNTL Pharma is dedicated to driving innovation, efficiency, and excellence in every project.

​

​